[HTML][HTML] Non-steroidal anti-inflammatory drugs administered intra-articularly in temporomandibular joint disorders: a systematic review and meta-analysis

F Bliźniak, M Chęciński, K Chęcińska… - Journal of Clinical …, 2024 - mdpi.com
Objectives: This systematic review was designed to summarize randomized controlled trials
of intra-articular administration of non-steroidal anti-inflammatory drugs (NSAIDs) for …

[HTML][HTML] BCLA CLEAR presbyopia: Management with scleral techniques, lens softening, pharmaceutical and nutritional therapies

SA Naroo, CA Woods, R Gil-Cazorla, RE Ang… - Contact Lens and …, 2024 - Elsevier
The aging eye undergoes the same progressive crosslinking which occurs throughout the
body, resulting in increased rigidity of ocular connective tissues including the lens and the …

Estimation of the full shape of the crystalline lens from OCT: validation using stretched donor lenses

E Martínez-Enríquez, B Maceo Heilman… - Biomedical optics …, 2023 - opg.optica.org
Quantifying human crystalline lens geometry as a function of age and accommodation is
important for improved cataract and presbyopia treatments. In previous works we presented …

Topical application of deglycating enzymes as an alternative non-invasive treatment for presbyopia

JR Delanghe, J Beeckman, K Beerens… - International journal of …, 2023 - mdpi.com
Presbyopia is an age-related vision disorder that is a global public health problem. Up to
85% of people aged≥ 40 years develop presbyopia. In 2015, 1.8 billion people globally had …

[HTML][HTML] Efficacy and safety of CSF-1 (0.4% pilocarpine hydrochloride) in presbyopia: pooled results of the NEAR phase 3 randomized, clinical trials

E Holland, P Karpecki, M Fingeret, J Schaeffer… - Clinical Therapeutics, 2024 - Elsevier
Purpose This study was undertaken to evaluate the safety and efficacy of CSF-1 (0.4%
pilocarpine hydrochloride ophthalmic solution) for use in individuals with presbyopia …

Extract from Aronia melanocarpa, Lonicera caerulea, and Vaccinium myrtillus Improves near Visual Acuity in People with Presbyopia

D Szumny, AZ Kucharska, K Czajor, K Bernacka… - Nutrients, 2024 - mdpi.com
Presbyopia is a global problem with an estimated 1.3 billion patients worldwide. In the area
of functional food applications, dietary supplements or herbs, there are very few reports …

Pharmacological treatments for the correction of presbyopia

HF Jiménez-Ortiz, NT Fernández - Archivos de la Sociedad Española de …, 2024 - Elsevier
Abstract Presbyopia affects between 1.7 and 2 billion people worldwide. Presbyopia
significantly impacts productivity and quality of life in both developed and developing …

Estrategias farmacológicas para la corrección de la presbicia

HF Jiménez-Ortiz, NT Fernández - Archivos de la Sociedad Española de …, 2024 - Elsevier
La presbicia afecta a entre 1.700 y 2.000 millones de personas en todo el mundo. La
presbicia impacta significativamente la productividad y la calidad de vida tanto en países …

[PDF][PDF] Correction of presbyopia using 0.5% pilocarpine eye drops among Indians

S Petkar, MC Chaitra - Bioinformation, 2024 - bioinformation.net
Pharmacological treatment of presbyopia-spectacle free senescence Therefore, it is of
interest to estimate improvement of near vision with 0.5% pilocarpine drops in presbyopic …

Conservantes en formulaciones oftálmicas: revisión narrativa sobre mitos, verdades y novedades

B Liviero, MC Marini - Oftalmología Clínica y Experimental, 2024 - revistaoce.com
Con el envejecimiento y ante el aumento de la expectativa de vida, las personas tienen más
posibilidades de desarrollar patologías crónicas como glaucoma, ojo seco y cuadros de …